EUCTR2011-005982-18-ES进行中（未招募）不适用
Randomized, placebo-controlled and double blind clinical trial to assess the efficacy of ubidecarenone in patients diagnosed with fibromyalgia
Mónica Saldaña Valderas0 个研究点开始时间: 2012年10月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male and female between 18 and 65 years of age
- •Patients diagnosed with fibromyalgia according to the American College of Rheumatology 2010 criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 112
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.- Patients diagnosed with rheumatologic diseases: rheumatoid artritis, ankylosing spondylitis, psoriatic arthritis, systemic lupus erytematosus, crystalline arthritis or osteoarthrosis.
- •2.- Severe systemic diseases, including cardiopulmonary, neurologic, renal or infectious diseases or any other condition that may affect the study
- •3.- Patients with severe mental disorders (psychotic, depressive or maniac disorders, suicide attempt, toxic abuse, and/or any psychical or physical disorders
- •4.- Patients receiving Coenzyme Q10, antidepressants, statins or tramadol
- •4.- Patients with pain due to other chronic diseases
- •5.- Pregnant and breastfeeding women.
研究者
相似试验
进行中（未招募）
1 期
Clinical investigation of the safety and anti-diabetic efficacy of the Rauvolfia-Citrus decoctioon-insulin dependent diabetes mellitusMedDRA version: 14.1Level: LLTClassification code 10012637Term: Diabetes with peripheral circulatory disordersSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 14.1Level: LLTClassification code 10045248Term: Type II diabetes mellitus with other specified manifestationsSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: LLTClassification code 10045252Term: Type II diabetes mellitus without mention of complicationSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: LLTClassification code 10012640Term: Diabetes with unspecified complicationsSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-000436-25-DKFrederiksberg University Hospital250
招募中
2 期
Homeopathic treatment for warty non cancerous growth of the voice boxCTRI/2011/12/002277Indian Council of Medical Research40
已完成
不适用
Evaluation of bupropion effects on cancer related fatigue in patients with cancerIRCT201706191497N7Vice Chancellor for Research,Isfahan University of Medical Sciences50
进行中（未招募）
不适用
Randomized, Double-blind, and Placebo-controlled a Clinical Study for Growing of Stature via the Analysis of Effect of Ferment Oyster Extract : Study ProtocolKCT0004408Pusan National University Korean Medicine Hospital100
进行中（未招募）
1 期
A study to test whether different doses of BI 690517 alone or in combination with empagliflozin improve kidney function in people with chronic kidney diseaseMedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disorderschronic kidney diseaseEUCTR2021-001434-19-ESBoehringer Ingelheim España S.A.552